157 related articles for article (PubMed ID: 24557439)
1. Comparison of perioperative outcomes and complication rates between conventional versus robotic-assisted laparoscopy in the evaluation and management of early, advanced, and recurrent stage ovarian, fallopian tube, and primary peritoneal cancer.
Nezhat FR; Finger TN; Vetere P; Radjabi AR; Vega M; Averbuch L; Khalil S; Altinbas SK; Lax D
Int J Gynecol Cancer; 2014 Mar; 24(3):600-7. PubMed ID: 24557439
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis.
Bellia A; Vitale SG; Laganà AS; Cannone F; Houvenaeghel G; Rua S; Ladaique A; Jauffret C; Ettore G; Lambaudie E
Arch Gynecol Obstet; 2016 Sep; 294(3):615-22. PubMed ID: 27040423
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers.
Nezhat FR; Denoble SM; Cho JE; Brown DN; Soto E; Chuang L; Gretz H; Saharia P
JSLS; 2012; 16(4):511-8. PubMed ID: 23484556
[TBL] [Abstract][Full Text] [Related]
4. Perioperative outcomes of robotic assisted laparoscopic surgery versus conventional laparoscopy surgery for advanced-stage endometriosis.
Nezhat FR; Sirota I
JSLS; 2014; 18(4):. PubMed ID: 25489208
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.
Nezhat FR; DeNoble SM; Liu CS; Cho JE; Brown DN; Chuang L; Gretz H; Saharia P
JSLS; 2010; 14(2):155-68. PubMed ID: 20932362
[TBL] [Abstract][Full Text] [Related]
6. Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy.
Magrina JF; Cetta RL; Chang YH; Guevara G; Magtibay PM
Gynecol Oncol; 2013 May; 129(2):336-40. PubMed ID: 23357611
[TBL] [Abstract][Full Text] [Related]
7. Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial.
Salehi S; Åvall-Lundqvist E; Legerstam B; Carlson JW; Falconer H
Eur J Cancer; 2017 Jul; 79():81-89. PubMed ID: 28463759
[TBL] [Abstract][Full Text] [Related]
8. Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Stashwick C; Post MD; Arruda JS; Spillman MA; Behbakht K; Davidson SA; Kelly MG
Int J Gynecol Cancer; 2011 Nov; 21(8):1422-7. PubMed ID: 21997170
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical and economic outcomes between robotic, laparoscopic, and open rectal cancer surgery: early experience at a tertiary care center.
Ramji KM; Cleghorn MC; Josse JM; MacNeill A; O'Brien C; Urbach D; Quereshy FA
Surg Endosc; 2016 Apr; 30(4):1337-43. PubMed ID: 26173546
[TBL] [Abstract][Full Text] [Related]
10. Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma.
Bouter ELM; Lok C; Trum H
Curr Opin Oncol; 2022 Sep; 34(5):490-496. PubMed ID: 35943438
[TBL] [Abstract][Full Text] [Related]
11. Robot-assisted versus laparoscopic surgery for lower rectal cancer: the impact of visceral obesity on surgical outcomes.
Shiomi A; Kinugasa Y; Yamaguchi T; Kagawa H; Yamakawa Y
Int J Colorectal Dis; 2016 Oct; 31(10):1701-10. PubMed ID: 27599703
[TBL] [Abstract][Full Text] [Related]
12. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
[TBL] [Abstract][Full Text] [Related]
13. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.
Janco JM; Hacker MR; Konstantinopoulos PA; Cannistra SA; Awtrey CS
J Minim Invasive Gynecol; 2011; 18(5):629-33. PubMed ID: 21803662
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Andikyan V; Kim A; Gretz HF; Zakashansky K; Prasad-Hayes M; Beddoe AM; Dottino P; Mandeli J; Chuang L
Am J Clin Oncol; 2018 Oct; 41(10):938-942. PubMed ID: 29624506
[TBL] [Abstract][Full Text] [Related]
16. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey.
Greggi S; Falcone F; Scaffa C; du Bois A; Samartzis EPP; Pujade-Lauraine E; Cibula D; Mądry R; Korach J; Gungorduk K; McNeish IA; Zanagnolo V; Marth C; van Altena AM; Aravantinos G; Sehouli J; Vergote I; Gonzalez Martin A
Int J Gynecol Cancer; 2020 Jun; 30(6):819-824. PubMed ID: 32354792
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.
Einenkel J; Ott R; Handzel R; Braumann UD; Horn LC
Int J Gynecol Cancer; 2009 Oct; 19(7):1288-97. PubMed ID: 19823067
[TBL] [Abstract][Full Text] [Related]
19. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers.
Krill LS; Ueda SM; Gerardi M; Bristow RE
Gynecol Oncol; 2011 Feb; 120(2):220-3. PubMed ID: 21145096
[TBL] [Abstract][Full Text] [Related]
20. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
